Expanscience (Prexidine Assets) Overview

  • Founded
  • 1979
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 63
Employees
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Expanscience (Prexidine Assets) General Information

Description

A pharmaceutical drug. The asset is a drug which is used for the treatment of extra mouth infections, or care after surgery in the oral cavity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • 10, avenue de l'Arche
  • 92419 Courbevoie
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Expanscience (Prexidine Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Expanscience (Prexidine Assets)‘s full profile, request access.

Request a free trial

Expanscience (Prexidine Assets) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Expanscience (Prexidine Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Expanscience (Prexidine Assets)‘s full profile, request access.

Request a free trial